Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.58% | 177.12 | 0.7% | $1156.59m | |
| LLY | Eli Lilly & Co. | 0.96% | 372.06 | 1.1% | $1068.92m | |
| MRK | Merck & Co., Inc. | 1.06% | 110.08 | 0.7% | $1002.54m | |
| PFE | Pfizer Inc. | 1.09% | 50.25 | 0.9% | $935.84m | |
| ABBV | AbbVie, Inc. | 0.98% | 165.32 | 1.9% | $895.13m | |
| BMY | Bristol-Myers Squibb Co. | 0.01% | 79.93 | 1.1% | $742.00m | |
| AZN | AstraZeneca Plc | 0.42% | 68.85 | 1.0% | $354.37m | |
| HZNP | Horizon Therapeutics Plc | -0.57% | 96.30 | 5.4% | $286.44m | |
| GSK | GSK Plc | -2.74% | 36.88 | 0.3% | $251.05m | |
| IDXX | IDEXX Laboratories, Inc. | 1.13% | 420.10 | 3.9% | $191.38m | |
| NVS | Novartis AG | 1.09% | 91.73 | 0.2% | $188.48m | |
| CTLT | Catalent, Inc. | -2.05% | 47.23 | 1.9% | $170.45m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5.32% | 231.33 | 8.0% | $168.15m | |
| NVO | Novo Nordisk A/S | -0.42% | 125.26 | 0.1% | $152.07m | |
| SNY | Sanofi | -1.26% | 47.94 | 0.2% | $138.09m |
Company Profile
GBT is a clinical-stage biopharmaceutical company that focuses on discovering, developing, and delivering innovative treatments that provide hope to underserved patient communities. GBT is developing its product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. It was founded in 2012 and is headquartered in San Francisco, California.